MedWatch

GN Hearing maintains guidance – still predicts 25 percent growth for 2021

Hearing aid company GN Hearing maintains its guidance for 2021 from the firm's presentation of its annual report in February. Thus, it forecasts that its revenue will grow more than 25 percent organically.

Photo: GN Store Nord / PR

Denmark-based company GN Hearing maintains its guidance for 2021, and thus, still envisions organic growth in the 25 percent range and an earnings before interest, taxation and amortization (EBITA) margin at more than 16 percent, which the company communicates in an announcement to the stock exchange on Wednesday morning in a financial update containing preliminary figures for the firm's Q1.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs